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Abstract
 
Wallerian degeneration and dying-back pathology are two well-known cellular pathways capable of regulating
 
the breakdown and loss of axonal and synaptic compartments of neurons 
 
in vivo
 
. However, the underlying mech-
anisms and molecular triggers of these pathways remain elusive. Here, we show that loss of translation elongation
factor 
 
eEF1A2
 
 expression in lower motor neurons and skeletal muscle fibres in homozygous 
 
Wasted
 
 mice triggered
a dying-back neuropathy. Synaptic loss at the neuromuscular junction occurred in advance of axonal pathology and
by a mechanism morphologically distinct from Wallerian degeneration. Dying-back pathology in 
 
Wasted
 
 mice was
 
accompanied by reduced expression levels of the zinc finger protein ZPR1, as found in other dying-back neuropathies
such as spinal muscular atrophy. Surprisingly, experimental nerve lesion revealed that Wallerian degeneration was
significantly delayed in homozygous 
 
Wasted 
 
mice; morphological assessment revealed that ~80% of neuromuscu-
lar junctions in deep lumbrical muscles at 24 h and ~50% at 48 h had retained motor nerve terminals following
tibial nerve lesion. This was in contrast to wild-type and heterozygous 
 
Wasted
 
 mice where < 5% of neuromuscular
junctions had retained motor nerve terminals at 24 h post-lesion. These data show that 
 
eEF1A2
 
 expression is
required to prevent the initiation of dying-back pathology at the neuromuscular junction 
 
in vivo
 
. In contrast, loss
of 
 
eEF1A2
 
 expression significantly inhibited the initiation and progression of Wallerian degeneration 
 
in vivo
 
. We
conclude that loss of 
 
eEF1A2
 
 expression distinguishes mechanisms underlying dying-back pathology from those
responsible for Wallerian degeneration 
 
in vivo
 
 and suggest that 
 
eEF1A2
 
-dependent cascades may provide novel
molecular targets to manipulate neurodegenerative pathways in lower motor neurons.
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Introduction
 
Pathways regulating neuronal vulnerability 
 
in vivo
 
 are of
critical importance to our understanding of a wide spectrum
of neurodegenerative disorders from Alzheimer’s disease
to motor neuron disease. A significant body of evidence
now suggests that the maintenance of neuronal viability is
compartmentalized within neurons, as cell soma, axons
and synapses are all capable of independent regulation.
One significant consequence of this compartmentalization
is that distal neuronal compartments such as axons and
synapses are particularly sensitive to perturbations of
neuronal homeostasis (Gillingwater & Ribchester, 2001;
Coleman, 2005; Gillingwater et al. 2006; Wishart et al. 2006;
Bettini et al. 2007; Saxena & Caroni, 2007; Baxter et al. 2008).
Several apparently distinct cellular pathways are known
 
to be capable of bringing about the degeneration of axons
and synaptic terminals, including dying-back pathology
and Wallerian degeneration (WD). For example, several
different motor neuron diseases and sensory neuropathies
are thought to occur primarily via dying-back pathways
(Schmalbruch et al. 1991; Frey et al. 2000; Cifuentes-Diaz
et al. 2002; Fischer et al. 2004; Keswani et al. 2006; Murray
et al. 2008), whereas conditions such as multiple sclerosis
and degeneration after traumatic nerve injury are more
commonly associated with WD (Ferguson et al. 1997; Perry
& Anthony, 1999; Gillingwater & Ribchester, 2001). Morpho-
logically, WD is characterized by rapid axonal and synaptic
fragmentation associated with disruption and loss of
 
organelles and plasma membranes, breakdown of the axonal
myelin sheath, and phagocytosis of synaptic and axonal
debris by cells including Schwann cells and invading macro-
phages (for review see Gillingwater & Ribchester, 2001). At the
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neuromuscular junction (NMJ), this process is characterized
by an early depletion of synaptic vesicles, swollen and burst
mitochondria, a breakdown of pre-synaptic plasma mem-
branes and terminal Schwann cell processes penetrating
into the synaptic cleft (Miledi & Slater, 1970; Winlow &
Usherwood, 1975; Gillingwater et al. 2003). By contrast,
dying-back neuropathies are characterized by a wave of
degeneration beginning at, and progressing retrogradely
from, the distal extremities of the neuron. Here, the early
withdrawal/retraction of synaptic terminals at the NMJ occurs
via a process devoid of the gross fragmentation associated
 
with WD and more akin to a progressive reabsorption of
synaptic and distal axonal organelles and plasma membranes
back into the parent axon (for review see Gillingwater &
Ribchester, 2003). Despite these clear morphological differ-
ences little is known about the extent to which their under-
ling molecular mechanisms converge or diverge (Coleman,
2005; Hoopfer et al. 2006). However, evidence has been
presented suggesting that morphologically distinct degener-
ation pathways can share common mechanistic links (Cole-
man, 2005; Mi et al. 2005). More detailed knowledge of the
cellular and molecular mechanisms that regulate and
perturb viability in distal neuronal compartments is there-
fore of significant importance for our understanding of the
healthy and pathological nervous system.
Here, we detail neuropathological changes occurring in the
peripheral nervous system of mice carrying a spontaneous
mutation that abolishes the expression of a gene encoding
the translation elongation factor 
 
eEF1A2 
 
[
 
Wasted
 
 (
 
Wst
 
);
Shultz et al. 1982; Chambers et al. 1998]. 
 
eEF1A
 
 (of which
there are two variant forms, i.e. 
 
eEF1A1
 
 and 
 
eEF1A2
 
) is the
second most abundant protein in non-proliferating cells,
constituting 1–2% of total protein and playing an integral
role in the elongation stages of protein synthesis during
which the polypeptide chain is assembled (Condeelis, 1995).
Alongside important roles in protein synthesis, eEF1A proteins
have also been postulated to have roles in non-canonical
pathways including modification of the cytoskeleton (Con-
deelis, 1995), the heat shock response (Shamovsky et al.
2006) and synaptic plasticity (Giustetto et al. 2003). Expression
patterns of the two variant forms (
 
eEF1A1
 
 and 
 
eEF1A2
 
)
are mutually exclusive in all cells and tissues examined. The
 
eEF1A2
 
 variant is only expressed in mature, terminally dif-
ferentiated neurons and muscle (Pan et al. 2004). Its post-
natal appearance in nerve and muscle coincides with loss of
 
eEF1A1
 
 expression. 
 
eEF1A1
 
 is expressed ubiquitously at the
time of birth but its expression in nerve and muscle declines
from the first post-natal week onwards, being absent by
post-natal day (P)20–21 (Pan et al. 2004). During this period
of declining 
 
eEF1A1
 
 expression in nerve and muscle, its role
is normally replaced by correlated increasing expression levels
 
of 
 
eEF1A2
 
 (Chambers et al. 1998; Khalyfa et al. 2001), with the
latter being the sole translation elongation factor by P21.
It has previously been shown that loss of 
 
eEF1A2
 
 results
in the degeneration of lower motor neurons in 
 
Wst
 
 mice,
characterized by vacuolation and neurofilament accumu-
lation in neuronal soma and denervation of skeletal
muscle fibres (Newbery et al. 2005). Importantly, the onset
of degeneration correlates precisely with the switch to
reliance on 
 
eEF1A2
 
 expression (Newbery et al. 2005) and it
has been conclusively demonstrated that the specific loss
of 
 
eEF1A2
 
 function is solely responsible for these events
(Newbery et al. 2007). Preliminary observations of the
morphological correlates of degeneration at the NMJ in
homozygous 
 
Wst
 
 mice (Newbery et al. 2005) highlighted
potential similarities to neuropathological events previ-
ously described in other mouse models of dying-back
neuropathy (e.g. Frey et al. 2000; Cifuentes-Diaz et al. 2002;
Fischer et al. 2004; Murray et al. 2008). However, dying-
back pathways were not conclusively demonstrated in this
study (Newbery et al. 2005). We have therefore under-
taken a detailed qualitative and quantitative analysis of
synaptic and axonal pathology in 
 
Wst
 
 mice to determine
whether dying-back pathways are indeed instigated
following the loss of 
 
eEF1A2
 
 expression 
 
in vivo
 
. We show
that the absence of normal post-natal 
 
eEF1A2
 
 expression
in 
 
Wst
 
 mice leads to early-onset degeneration of motor
nerve terminals, resulting in a dying-back pathology dis-
tinct from classic WD. Quantitative protein expression
experiments showed that dying-back pathology in 
 
Wst
 
mice correlated with reductions in expression levels of the
zinc finger protein ZPR1. Surprisingly, a parallel set of
nerve lesion experiments in homozygous
 
 Wst
 
 mice
revealed delayed WD of distal axons and synaptic termi-
nals, demonstrating that 
 
eEF1A2
 
 is required for the nor-
mal initiation and progression of WD pathways. These
experiments demonstrate that loss of 
 
eEF1A2
 
 expression
distinguishes mechanisms underlying dying-back path-
ways from those responsible for WD 
 
in vivo
 
.
 
Materials and methods
 
Mouse maintenance and surgery
 
Pairs of heterozygous 
 
Wst
 
 mice were kindly provided by Dr Cathy
Abbott (University of Edinburgh) and a breeding colony estab-
lished. Litters contained homozygous and heterozygous mice as
well as wild-type littermates. Heterozygous and wild-type litter-
mates were used throughout as controls. Breeding colonies of
 
YFP-H
 
 mice (Feng et al. 2000) were already established in animal
care facilities at the University of Edinburgh and were crossed
with 
 
Wst
 
 mice in order to obtain homozygous and heterozygous
 
Wst
 
 mice, as well as wild-type littermates, endogenously express-
 
ing yellow fluorescent protein (YFP) in a subset of neurons.
 
Smn–/–;SMN2
 
 mice (Monani et al. 2000) were obtained from existing
breeding colonies in Edinburgh. All mice were housed in a semi-
barrier facility and were fed a standard chow diet. 
 
Wst
 
, 
 
Wst;YFP-
H
 
 and 
 
Smn–/–;SMN2
 
 mice were genotyped using standard
polymerase chain reaction techniques, as described previously
 
(Newbery et al. 2005; Murray et al. 2008). The 
 
YFP
 
 status was
 
ascertained by examining ear punches for evidence of YFP-
 
labelled neurons. Mice were killed by overdose of isofluorane via
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inhalation or cervical dislocation. 
 
Wst
 
 mice and wild-type litter-
mates were killed at P20 for early-symptomatic data and P24
 
–
 
P27
for late-symptomatic data. All surgical procedures were per-
formed under general anaesthesia (inhalation of isofluorane;
 
2% in 1:1 N
 
2
 
O/O
 
2
 
) as described previously (Gillingwater et al. 2003).
All breeding and surgical procedures were carried out with the
licensed authority of the UK Home Office.
 
Immunohistochemistry
 
Muscles were immunohistochemically labelled to allow quantifi-
cation of neuromuscular innervation as described previously
 
(Murray et al. 2008). Briefly, muscles were immediately dissected from
recently killed mice and dissected in oxygenated mammalian
physiological saline before labelling post-synaptic acetylcholine
 
receptors with 
 
α
 
-bungarotoxin conjugated to tetramethylrhoda
 
-
 
mine isothiocyanate (5 
 
μ
 
g mL
 
−
 
1
 
 for 10 min, Molecular Probes, USA).
Muscles were then fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS) for 1–2 h. Non-YFP-expressing muscles were
then blocked in 4% bovine serum albumin and 1% TritonX in
 
0.1 
 
M
 
 PBS for 30 min before incubation overnight in primary
antibodies raised against either 165 kDa neurofilament proteins
and the synaptic vesicle protein SV2 (both 1:200, Developmental
Studies Hybridoma Bank, USA) or 150 kDa neurofilament proteins
(Chemicon, USA) and visualized with sheep anti-mouse fluorescein
isothiocyanate-conjugated secondary antibodies (1:200; Diagnos-
tics Scotland, UK) or swine anti-rabbit fluorescein isothiocyanate-
conjugated secondary antibodies (1:40; DAKO, USA), respectively.
Muscles were then whole-mounted in Mowoil® (Calbiochem) on
glass slides and coverslipped for subsequent imaging.
 
FM4–64FX labelling of neuromuscular synaptic function
 
Freshly dissected levator auris longus (LAL) muscles from 
 
Wst
 
;
 
YFP-
 
H
 
 mice were loaded with the styryl dye FM4–64FX using a high K
 
+
 
stimulus. Muscle preparations were exposed to a fixable form of
 
the styryl dye FM4–64 (FM4–64FX, 2 mg mL
 
−
 
1
 
; Molecular Probes) in
 
high K
 
+
 
 Krebs’ solution sparged with 95% : 5% O
 
2
 
 : CO
 
2
 
 (102 m
 
M
 
Na
 
+
 
, 50 m
 
M
 
 K
 
+
 
, 2 m
 
M
 
 Ca
 
2+
 
, 2 m
 
M
 
 Mg
 
2+
 
, 132 m
 
M
 
 Cl
 
−
 
, 23.8 m
 
M
 
 HCO
 
3
 
−
 
,
0.4 m
 
M
 
 , 5 m
 
M
 
 D-glucose, 5.5 m
 
M
 
 HEPES, pH 7.2–7.4) for
10 min. After rigorous washing, muscles were fixed in 4% para-
formaldehyde/PBS solution (Electron Microscopy Science, PA,
USA) and post-synaptic acetylcholine receptors were labelled with
 
α
 
-bungarotoxin conjugated to alexa-647 (5 
 
μ
 
g mL
 
−
 
1
 
 for 10 min,
Invitrogen, USA). Muscles were whole-mounted in Mowoil®
 
(Calbiochem) on glass slides and coverslipped for subsequent imaging.
 
Imaging and quantification
 
Immunohistochemically-labelled NMJs and YFP-expressing muscles
and nerves were imaged using either a standard epifluorescence
microscope equipped with a chilled charge-coupled device camera
(40
 
×
 
 objective; 0.8 NA; Nikon IX71 microscope; Hammamatsu
C4742-95; Improvision Openlab Software) or a laser scanning
 
confocal microscope (40
 
×
 
 objective; 0.8 NA; Radiance 2000,
Biorad, Hemel Hempstead, UK; Biorad Lasersharp 2000 Software).
Between 50 and 200 endplates, selected at random, were quanti-
fied from each muscle preparation. Wherever possible, all analysis
was performed without the operator knowing the status of the
material. For basic occupancy counts, the occupancy of individual
NMJs was evaluated by categorizing endplates as either fully
occupied (neurofilament/SV2 entirely overlies endplate), partially
occupied (neurofilament/SV2 partially covers endplate) or vacant
(no neurofilament/SV2 overlies endplate).
 
Montages and reconstructions
 
Reconstructions of immunohistochemically-labelled and YFP-H-
labelled muscle and nerve preparations were produced using
Adobe Photoshop software by layering and combining multiple
individual micrographs.
 
Electron microscopy
 
Nerve and muscle preparations were prepared for electron microscopy
as described previously (Gillingwater et al. 2003). Briefly, preparations
 
were fixed in 0.1 
 
M
 
 phosphate buffer containing 4% paraformalde-
hyde and 2.5% glutaraldehyde for 4 h before post-fixation in 1%
osmium tetroxide for 45 min. Following dehydration and propyl-
ene oxide stages, preparations were embedded in Durcupan resin.
Ultra-thin sections (75–90 nm) were cut and collected on formvar-
coated grids (Agar Scientific, UK), stained with uranyl acetate and
lead citrate in an ‘Ultrostainer’ (LKB), and then viewed in a trans-
mission electron microscope (CM12, Philips). Synaptic vesicle densities
were calculated as described previously (Gillingwater et al. 2003).
 
Quantitative fluorescent (Li-COR) western blots
 
Total protein was isolated from the spinal cord of late-symptomatic
 
Wst
 
 mice and control littermates as well as late-symptomatic
 
(P5/P6) 
 
Smn–/–;SMN2
 
 mice and control littermates (
 
N = 3 mice
per genotype; see Murray et al. 2008) and quantitative western
blots were performed as described previously (Wishart et al.
2007). Briefly, protein was separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis on 4–20% pre-cast NuPage 4–
12% Bis Tris gradient gels (Invitrogen) and then transferred to a
polyvinylidene difluoride membrane overnight. The membranes
were blocked using Odyssey blocking buffer (Li-COR Biosciences)
and incubated with primary antibodies as per the manufacturer’s
instructions (tubulin, Abcam; SMN1, BD Bioscience; ZPR1, BD Bio-
science). Odyssey secondary antibodies were added according to
the manufacturer’s instructions (goat anti-rabbit IRDye 680 and
goat anti-mouse IRDye 800). Blots were imaged using an Odyssey
Infrared Imaging System (Li-COR Biosciences). The scan resolution
of the instrument ranged from 21 to 339 μm and in this study
blots were imaged at 169 μm. Quantification was performed on
single channels with the analysis software provided. Bands were
identified according to their relative molecular weight and deline-
ated using Odyssey software and the arbitrary fluorescence
intensity calculated by the software. For each membrane, scans
were carried out at three different intensities in order to minimize
possible user error in determining correct scan intensities or over-
saturation of the membrane. The average of these three separate
scans (giving an N = 1 per membrane) was used for analysis.
Results
Loss of eEF1A2 expression triggers a dying-back 
neuropathy: synaptic pathology
In order to investigate the cellular pathway(s) through which
lower motor neurons degenerate following perturbations
H PO2 4
2−
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in expression of the translation elongation factor eEF1A2
in Wst mice, we used confocal and electron microscopy to
examine the detailed morphological correlates of neuro-
muscular pathology in two muscle groups previously
shown to be affected in Wst mice, i.e. transversus
abdominis from the anterior abdominal wall and deep
lumbrical muscles from the hind-paw (Newbery et al.
2005). In both of these muscle groups, immunohistochem-
ical labelling of distal axons and pre-synaptic motor nerve
terminals confirmed previous reports of a significant loss
of innervation at the NMJ in late-symptomatic (P24–P27)
homozygous Wst mice, characterized by partially occupied
and vacant endplates (Fig. 1). Partial occupancy of end-
plates by overlying motor nerve terminals is a morpholog-
ical correlate associated with dying-back pathways,
distinct from the rapid in-situ fragmentation occurring
at the NMJ during WD (Miledi & Slater, 1970; Winlow &
Usherwood, 1975; Fischer et al. 2004; Murray et al. 2008).
We extended these observations to include other muscle
groups, finding evidence for similar synaptic pathology in
the LAL muscle from the dorsal aspect of the head and flexor
digitorum brevis muscle from the plantar aspect of the hind-
paw (Fig. 2). In keeping with previous reports of a rostrocaudal
progression of motor neuron degeneration in Wst mice,
pathology was more severe in neurons supplying the LAL
than those innervating the flexor digitorum brevis (cf. Fig. 2
in the current paper with Fig. 6 in Newbery et al. 2005).
Closer examination of the distinct rostral and caudal bands
of the LAL muscle, known to be differentially affected by
dying-back pathology in mouse models of spinal muscular
atrophy (SMA) (Murray et al. 2008), showed similar levels of
synaptic pathology in each band (data not shown).
We next examined the ultrastructure of degenerating
NMJs in late-symptomatic Wst mice (Fig. 1D and E). In all
preparations examined (> 200 NMJs in total), we never
observed any of the classical ultrastructural markers of WD
(Miledi & Slater, 1970; Winlow & Usherwood, 1975). Motor
nerve terminal plasma membranes remained intact, even
during the process of retraction (as shown by partially
occupied motor endplates; Fig. 1D and E). Similarly, nerve
terminal organelles such as mitochondria and synaptic
vesicles could clearly be identified and terminal Schwann cells
were never observed engulfing or phagocytosing nerve
terminals (Fig. 1D and E, and H and I). One other conspicu-
ous morphological feature of Wst motor nerve terminals
and distal axons was a conspicuous accumulation of neuro-
filaments (Fig. 1F–H), once again appearing very similar
to previous reports of other dying-back neuropathies
(Cifuentes-Diaz et al. 2002; Murray et al. 2008).
As mitochondrial fragmentation and synaptic vesicle
depletion are two of the major hallmarks of WD (Miledi &
Slater, 1970; Winlow & Usherwood, 1975), we undertook
a more detailed ultrastructural investigation of these
organelles. The vast majority of nerve terminal mitochondria
remained intact (Fig. 1I) with the numbers of mitochon-
dria displaying a disrupted morphology being consistently
less than those previously described in normal ‘healthy’
nerve terminals (<10%; Winlow & Usherwood, 1975).
Quantification of synaptic vesicle densities (see Materials
and methods) revealed that, rather than vesicles being
depleted in nerve terminals, the density of vesicles actually
increased in Wst mice at both P20 and P26 (Fig. 1J). Thus,
all of the morphological features of degeneration at the
NMJ in Wst mice were characteristic of a retraction process
more akin to dying-back pathology than classical WD.
As such an increase in synaptic vesicle numbers may
imply altered synaptic function, we examined pre-synaptic
function at the NMJ in late-symptomatic (P25)
homozygous Wst;YFP-H mice using the vital styryl dye
FM4–64 (see Materials and methods). The use of Wst;YFP-
H mice allowed us to examine synaptic function at intact
motor nerve terminals, indicated by the presence of YFP
label (see below). As expected, all motor nerve terminals
showed uptake of FM4–64 in LAL muscles from wild-type
and heterozygous Wst;YFP-H littermate mice (N = 4 muscles).
However, examples of intact motor nerve terminals with
no FM4–64 uptake were observed in all LAL muscles from
homozygous Wst;YFP-H mice (N = 4 muscles; Fig. 3). These
data suggest that the presence of large numbers of synaptic
vesicles in motor nerve terminals can be explained by the
functional machinery required for exocytosis/endocytosis
being impaired as part of the dying-back process in Wst
mice. Thus, functional loss preceded morphological
retraction, as previously reported for other dying-back
neuropathies (Balice-Gordon et al. 2000; Pun et al. 2006).
Loss of eEF1A2 expression triggers a dying-back 
neuropathy: axonal pathology
Although the disruption of NMJs was clearly an early path-
ological event in Wst mice, it remained unclear whether
neuromuscular synapses and their distal axon collaterals
were the initial site of neurodegeneration or whether
proximal axonal degeneration back in the main peripheral
nerve trunk was occurring concurrently or in advance. This
remained a critical point to address as the classic criterion
for a dying-back pathology defines a distal to proximal
initiation and progression of pathology. To address this
question, we cross-bred Wst mice with thy1YFP-H mice
endogenously expressing YFP in a small subset of motor
neurons (Feng et al. 2000). Homozygous Wst;YFP-H mice
were phenotypically indistinguishable from non-YFP-
expressing Wst mice, developing the same symptoms over
the same time-course (data not shown).
Whole intercostal nerves supplying the transversus
abdominis (which at the time-point examined showed
signs of severe synaptic pathology) and tibial nerves
supplying the lumbrical muscles (which at the time-point
examined showed signs of more modest synaptic pathology)
were dissected from late-symptomatic (P25) Wst;YFP-H mice
eEF1A2 and neurodegeneration, L. M. Murray et al.
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Fig. 1 Synaptic loss at the NMJ in Wst mice occurs by a pathway morphologically distinct from WD. (A) Confocal micrograph showing a normal, control 
NMJ in an immunohistochemically-labelled transversus abdominis (TVA) muscle preparation from a P21 wild-type littermate mouse [green, 165 kDa 
neurofilaments and SV2; red, post-synaptic acetylcholine receptors labelled with α-bungarotoxin conjugated to tetramethylrhodamine isothiocyanate 
(TRITC-α-bungarotoxin)]. (B) Electron micrograph showing a normal, control NMJ in a lumbrical muscle preparation from a P25 wild-type littermate 
mouse. (C) Confocal micrograph showing two partially occupied NMJs in an immunohistochemically-labelled TVA muscle preparation from a P21 Wst 
mouse (green, 165 kDa neurofilaments and SV2; red, post-synaptic acetylcholine receptors labelled with TRITC-α-bungarotoxin). Partial occupancy of 
endplates is a morphological characteristic associated with nerve terminal retraction (e.g. dying-back) processes rather than WD. Electron micrographs 
showing partially occupied NMJs (identified by regions of vacant post-synaptic folds; blue arrows) in the flexor digitorum brevis (D) and lumbrical (E) 
muscles from late-symptomatic (P25) Wst mice. Note how the remaining motor nerve terminal boutons show none of the characteristic ultrastructural 
signs of WD; mitochondria, synaptic vesicles and pre-synaptic plasma membranes were all present and intact, and there was no evidence of phagocytosis 
by the terminal Schwann cell. (F) Confocal micrograph showing characteristic neurofilament accumulation, alongside interspersed thinning, in distal 
axons (blue and yellow arrows respectively) and motor nerve terminals from a P25 Wst mouse lumbrical muscle. (G) Electron micrograph showing a 
cross-sectional profile of an axon from the intramuscular region of an intercostal nerve supplying the TVA muscle in a P26 Wst mouse. Note the 
presence of large neurofilament accumulations in the axonal cytoplasm (cf. F) and the absence of any degenerative characteristics; the myelin sheath and 
axonal membranes remain intact. (H) Electron micrograph showing a NMJ in the flexor digitorum brevis muscle from a P26 Wst mouse. Note the 
presence of large neurofilament accumulations in the motor nerve terminal (blue arrows) but the lack of any morphological characteristics of WD 
(see above). (I) High-power electron micrograph showing three mitochondria in a motor nerve terminal from the flexor digitorum brevis muscle of a 
P26 Wst mouse. Note how the mitochondrial membranes and cristae are preserved (disruption of mitochondrial morphology is one of the earliest signs 
of WD). (J) Bar chart (mean ± SEM) showing significant increases in synaptic vesicle densities in motor nerve terminals from the lumbrical muscles of 
Wst mice at P20 (early-symptomatic) and P26 (late-symptomatic) compared with wild-type littermates (**P < 0.01 for both ages, ANOVA with Tukey’s 
post-hoc test; N = 24 nerve terminals and n = 6694 vesicles in P20 wild-type, N = 20 and n = 3540 in P20 Wst, N = 26 and n = 8071 in P26 Wst). 
Synaptic vesicles are normally depleted from motor nerve terminals during WD. Scale bars: 10 μm (A), 15 μm (C), 0.75 μm (B, D and E), 20 μm 
(F), 0.75 μm (G), 1 μm (H), 0.1 μm (I).
eEF1A2 and neurodegeneration, L. M. Murray et al.
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(N = 4 intercostal nerves, N = 4 tibial nerves). Individual
YFP-expressing axons were then imaged and reconstructed
over a minimum distance of 1 mm (Fig. 4A and B). In all nerves
examined, we never observed any signs of axonal degener-
ation. All individual YFP-labelled axons were intact along
their entire length, with no evidence of axonal breaks,
axon fragmentation or spheroid formation (Fig. 4A–C; cf.
Beirowski et al. 2005). To confirm these observations, we
also examined semi-thin toluidine-blue-stained sections of
intercostal (n = 11 sections, N = 4 nerves) and tibial (n = 10
sections, N = 2 nerves) nerves from late-symptomatic
P24 Wst mice (Fig. 4D). In all sections examined < 0.5% of
axons were classified as having a ‘degenerative’ morpho-
logy (e.g. disrupted myelin sheath and/or axonal profile).
Ultrastructural analyses of proximal and intramuscular
axons from end-stage (P27) Wst mice again showed no
evidence of gross axonal pathology (Fig. 4E). These data
therefore reveal that synaptic loss occurs significantly in
advance of axonal pathology in Wst mice, supporting the
hypothesis that synaptic compartments of neurons are
particularly sensitive to altered levels of eEF1A2.
Synapse loss occurs asynchronously within single 
motor units in Wst mice
As WD is known to bring about a relatively synchronous
and rapid (i.e. within several hours) degeneration of NMJs
(Miledi & Slater, 1970), whereas dying-back neuropathies
are characterized by a progressive asynchronous loss of
nerve terminals, we examined patterns of synaptic patho-
logy occurring within the entire cohort of motor nerve
terminals in single YFP-labelled motor units of Wst;YFP-H
mice. We reconstructed and analysed synaptic cohorts of
single motor units supplying LAL muscles from five late-
symptomatic Wst;YFP-H mice (Fig. 5 and Supporting Infor-
mation Fig. 1). Branching diagrams produced by tracing
individual labelled motor units (N = 5) revealed a common
response, with all motor neurons seemingly affected to a
similar level (i.e. all motor units exhibited clear evidence of
synaptic pathology). However, each motor unit displayed
a heterogeneous range of synaptic morphologies, includ-
ing intact synapses (fully occupied) and synapses at various
stages of dismantling (partially occupied). Comparison of
Fig. 2 Synaptic pathology extends to the flexor digitorum brevis (FDB) and levator auris longus (LAL) muscles in symptomatic Wst mice. Confocal 
micrographs showing NMJs in immunohistochemically-labelled LAL (A) and FDB (B) muscle preparations from P25 Wst mice (green, 165 kDa 
neurofilaments and SV2; red, post-synaptic acetylcholine receptors labelled with α-bungarotoxin conjugated to tetramethylrhodamine isothiocyanate). 
Partially occupied (white arrows in B) and vacant (white arrow in A) endplates were present throughout both muscle groups, as previously observed 
in transversus abdominis (TVA) and lumbrical muscles (Fig. 1 in the current paper; Newbery et al. 2005). Occasionally, remnants of synaptic terminals 
and distal axons withdrawing from post-synaptic endplates were observed (‘retraction bulbs’; blue arrow in A). (C) Bar chart (mean ± SEM) showing 
the percentage of fully occupied endplates, partially occupied endplates and vacant endplates in LAL muscles from wild-type mice at P20 (WT P20; 
black bars; N = 2 mice), Wst mice at P20 (−/− P20; N = 3 mice) and Wst mice at P25 (−/− P25; N = 4 mice). Note how the percentage of fully occupied 
endplates declines and the percentage of vacant endplates increases with advancing age in Wst mice. Similar loss of pre-synaptic innervation was 
observed in FDB muscles at P25, albeit to a lesser extent than in LAL or TVA (as in neighbouring lumbrical muscles; ~30–40% of NMJs showed disrupted 
morphology; data not shown). Scale bars: 20 μm (A), 15 μm (B).
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the innervation states of neighbouring synapses that
shared a single branch point showed that synapses were
being lost progressively and asynchronously in Wst mice.
This finding indicates that local mechanisms, resident at
individual synapses, are likely to play an important role in
determining an individual synapse’s response to the effects
of a loss of eEF1A2. Taken together with the other data
presented above, these experiments demonstrate that dis-
ruption of eEF1A2 in lower motor neurons and skeletal
muscle fibres triggers dying-back pathways.
Molecular correlates of dying-back neuropathy in 
Wst mice: a role for ZPR1?
Although eEF1A2-specific mutations are not thought to be
directly responsible for any human neurodegenerative
conditions, the gene and its protein product share notable
molecular linkages with other proteins known to be
involved in the pathogenesis of other dying-back neuro-
pathies such as the childhood motor neuron disease
SMA. For example, eEF1A proteins assemble into com-
plexes with the survival motor neuron protein (SMN1;
where mutations abolish expression and cause SMA) and
a zinc finger protein (ZPR1) (Gangwani et al. 1998; Mishra
et al. 2007). Interestingly, the dying-back pathology
observed following disruption of eEF1A2 in Wst mice
closely mirrors morphological correlates of lower motor
neuron pathology occurring in mouse models of SMA and
also in ZPR1-deficient mice (Monani et al. 2000, 2003;
Doran et al. 2006; Murray et al. 2008). Therefore, we
quantified levels of Smn protein in the spinal cord of late-
symptomatic Wst mice (P25) and littermate controls using
fluorescent (Li-COR) western blots to test whether the
dying-back pathology in Wst mice could simply be
accounted for by reduced levels of Smn protein resulting
from decreased eEF1A2 expression. Smn levels remained
relatively stable in homozygous Wst mice, showing a slight
trend towards increased rather than decreased expression
levels (Fig. 6). This was in stark contrast to the significant
reduction in Smn levels observed in the spinal cord of late-
symptomatic Smn–/–;SMN2 mice (an established mouse
model of severe SMA) (Monani et al. 2000; Murray et al.
2008). Thus, the dying-back pathology observed in Wst
mice could not be simply attributed to downstream
changes in Smn protein levels. Next, we asked a similar
question but this time focusing on levels of ZPR1 protein
expression. Interestingly, ZPR1 protein levels were found
to be consistently reduced in Wst mice, to a level similar to
that found in Smn–/–;SMN2 mice (Fig. 6). As reduced ZPR1
levels have been suggested to contribute to dying-back
pathology in SMA (Gangwani et al. 2001; Helmken et al.
2003), a similar reduction in Wst mice may provide evi-
dence for a common regulatory role of ZPR1 in regulating
dying-back pathways in both Wst and Smn–/–;SMN2
mice.
Fig. 3 Functional loss precedes structural loss at NMJs undergoing 
dying-back pathology in Wst mice. Confocal micrograph (merge of all 
three channels in top panel with separate channels shown below) of 
NMJs from a P25 Wst;YFP-H mouse LAL muscle. Motor nerve terminals 
were loaded with FM4–64FX using a depolarizing high-potassium 
solution leading to the selective labelling of functionally-active terminals 
(i.e. with the retained ability to recycle synaptic vesicles). In the 
preparation shown, two NMJs with motor nerve terminals containing 
YFP can be seen but only one of these motor nerve terminals 
demonstrated retained functional ability (red arrow; note the presence 
of strong FM4–64FX label in the bottom panel). The junction indicated 
by the white arrow was present morphologically (as shown by the YFP 
label) but had lost its functional capacity to recycle synaptic vesicles and 
hence had not taken up the FM4–64FX label. Thus, synaptic function 
was lost before morphological retraction occurred in Wst mice. By 
contrast, in control preparations from YFP-H wild-type littermates, all 
motor nerve terminals showed strong FM4–64FX labelling (data not 
shown). Scale bar, 35 μm.
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eEF1A2 is required for the normal initiation and 
progression of axotomy-induced WD
As we found strong evidence that eEF1A2 is an important
regulator of dying-back pathways in vivo, we next asked
whether deficiencies in eEF1A2 also exert any influence on
WD pathways by studying responses to nerve injury in
homozygous Wst, heterozygous Wst and wild-type litter-
mate mice. For these experiments we examined lumbrical
muscles as the synaptic pathology resulting from dying-
back pathology was significantly less in these muscles com-
pared with more rostral muscle groups (Figs 1 and 2) (New-
bery et al. 2005), thereby minimizing the complexity of
distinguishing disease-induced changes from those
induced by nerve injury. Late-symptomatic (P24) Wst and
Wst;YFP-H mice (as well as wild-type and heterozygous
Wst littermates) were subjected to a unilateral tibial nerve
cut under general anaesthesia. Following recovery and
resumption of normal behaviour, mice were killed 24 h
later (P25) and their lumbrical muscles and tibial nerves
distal to the site of lesion were removed.
As expected, nerve lesion in wild-type littermate mice
resulted in a complete loss of neuromuscular innervation
at 24 h after surgery, via classical WD pathways character-
ized by rapid breakdown and fragmentation of pre-synap-
tic motor nerve terminals and distal axons (Fig. 7A and F).
Surprisingly, the vast majority (~80%) of motor nerve
terminals and their intramuscular axon collaterals remained
intact in lumbrical muscles from homozygous Wst mice at
24 h after nerve lesion (Fig. 7B and F). Similarly, the tibial
nerve distal to the site of nerve lesion showed no signs of
degeneration in homozygous Wst mice assayed using YFP-
H and ultrastructural techniques (Fig. 7C–E). As the tibial
nerve is a mixed motor/sensory nerve, these experiments
revealed that neither motor nor sensory axons showed
signs of degeneration in homozygous Wst mice. Examina-
tion for early axonal ultrastructural indicators of WD
(swelling and damage of mitochondria) (Miledi & Slater,
1970; Winlow & Usherwood, 1975) revealed subtle but
widespread changes in wild-type nerves (~50% of axons
examined showed mitochondrial changes or disruption of
the myelin sheath; Fig. 7D) but the almost complete
Fig. 4 Synaptic pathology occurs in the 
absence of axonal pathology in symptomatic 
Wst mice. Montage of fluorescence 
micrographs showing YFP-labelled axons in an 
intercostal nerve (A) (supplying the transversus 
abdominis muscle) and a tibial nerve 
(B) (supplying the lumbrical muscles) from P25 
Wst;YFP-H mice. Note that not all axons are 
labelled with YFP, allowing direct visualization 
and tracing of individual axons for several 
hundred microns. All labelled axons were intact 
over the entire length reconstructed in both 
nerves. This is in stark contrast to the 
fragmented appearance of axons undergoing 
WD (cf. Beirowski et al. 2005). (C) High-power 
fluorescence micrograph of an individual 
YFP-labelled axon in an intercostal nerve from a 
P25 Wst;YFP-H mouse showing intact axonal 
morphology. (D) Cross-section of a toluidine 
blue-stained intercostal nerve from a P24 Wst 
mouse. Less than 1% of axons examined using 
this approach showed any morphological signs 
of degeneration. (E) Electron micrograph of 
axons from an intramuscular region of 
intercostal nerve from a P26 Wst mouse, 
supporting analysis of toluidine blue-stained 
sections (D) by showing no evidence of axonal 
degeneration. All axons examined had normal 
myelin sheaths and axonal membranes. Scale 
bars: 200 μm (A), 450 μm (B), 25 μm (C), 
35 μm (D), 4 μm (E).
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absence of any early markers of WD in Wst nerves (only
one out of ~200 axons showed signs of disrupted mito-
chondria; Fig. 7E). Importantly, we were able to rule out
the possibility that the genetic background of the mice was
influencing the WD process by comparing homozygous Wst
mice with heterozygous and wild-type littermates (Fig. 7F).
In order to confirm that the significant inhibition of WD
found in homozygous Wst mice extended beyond the 24 h
period that we initially examined, we quantified degener-
ation in mice subjected to a unilateral tibial nerve cut at
P23 followed by killing 48 h later (P25). Even at 48 h post-
axotomy, approximately 50% of motor nerve terminals
and their intramuscular axon collaterals remained intact in
lumbrical muscles from homozygous Wst mice (Fig. 7G).
This contrasts with the situation in wild-type and hetero-
zygous littermates where almost all motor nerve terminals
(> 95%) had undergone degeneration after 24 h (Fig. 7F).
Fig. 6 Dying-back pathology in Wst mice occurs independently of 
changes in Smn protein expression but correlates with modest 
reductions in ZPR1 protein levels. (A) Representative fluorescent western 
blots showing levels of Smn and ZPR1 protein in Wst mice vs. control 
littermates (left panel) and Smn–/–;SMN2 mice vs. control littermates 
(right panel). (B) Bar chart (mean ± SEM) showing expression levels of 
Smn and ZPR1 protein in the mid-thoracic spinal cord of late-
symptomatic Wst (left bars; P25) and Smn–/–;SMN2 (right bars; P5) mice 
compared with respective control littermate mice, quantified using 
fluorescent western blots (N = 3 mice per genotype). Smn protein levels 
did not decrease in Wst mice (if anything showing a modest increase in 
expression) but, as expected, decreased by around 75% in 
Smn–/–;SMN2 mice. Thus, the dying-back pathology observed in Wst 
mice is not simply occurring due to reduced levels of Smn protein. ZPR1 
protein levels, however, were reduced by similar amounts in both Wst 
and Smn–/–;SMN2 mice.
Fig. 5 Asynchronous loss of synapses at the NMJ within single motor 
units in late-symptomatic Wst mice. (A) Montage of confocal micrographs 
showing a single YFP-H-labelled motor unit from a P25 Wst;YFP-H mouse 
(green, YFP; blue, post-synaptic acetylcholine receptors labelled with α-
bungarotoxin). (B) Higher power confocal micrograph showing a small 
region of the larger whole motor unit shown in A (position indicated by 
black arrow in A). Note how the first (far left) NMJ is fully occupied, the 
second (lower right) NMJ is partially occupied and the third (upper right) 
NMJ has lost its pre-synaptic input, remnants of which are left as a 
retraction bulb. (C) Branch diagram generated from an analysis of the 
single motor unit shown in A, with each individual NMJ represented as 
a circle relative to its branch point position within the motor unit. The 
occupancy status of each NMJ is represented by the colour of the circle 
(key to colours is on the right of the panel). Note how synaptic retraction 
occurred asynchronously throughout the motor unit, with a full spread 
of occupancies present. Note also how fully occupied (i.e. ‘normal’; red) 
NMJs were distributed at locations throughout the motor unit, as were 
almost fully retracted NMJs (blue). Scale bars: 500 μm (A), 50 μm (B).
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It was not possible to extend the time-course of our inves-
tigations much beyond this 48 h period because the oper-
ated mice did not live beyond P26 (due to the severity of
dying-back pathological changes in the more severely
affected rostral muscle groups) and mice could not be
operated earlier than P23 in order to ensure a complete
loss of eEF1A1 expression (cf. Pan et al. 2004). However,
these experiments demonstrate that eEF1A2 is required
for the normal initiation and progression of WD. These
data also further support the conclusion that the dying-
back pathways instigated following disruption of eEF1A2
in Wst mice are mechanistically distinct from WD, as WD
pathways are actually inhibited (rather than triggered) in
Wst mice.
Discussion
The experiments reported here raise four important con-
clusions. First, they demonstrate that the spontaneous loss
of eEF1A2 expression that occurs in Wst mutant mice trig-
gers dying-back pathways in lower motor neurons in vivo,
where synaptic loss at the NMJ is an early event. This
supports the hypothesis that synaptic compartments of
neurons are particularly sensitive to perturbations in neuronal
homeostasis (Gillingwater & Ribchester, 2001; Wishart
et al. 2006) and shows that eEF1A2 expression is essential
for the prevention of pre-synaptic degeneration in vivo.
Second, they show that eEF1A2 expression is required for
the normal initiation and progression of WD following nerve
injury in vivo. This finding adds significant support to previous
experimental studies suggesting that WD is an active,
genetically-regulated process, rather than a simple passive
consequence of disconnection from the parent cell body
(Mack et al. 2001; Coleman & Perry, 2002). Third, the experi-
ments show that degeneration of axons and synapses can
be regulated by at least two mechanistically-divergent
pathways. Specifically, dying-back pathology can be
caused by deficiencies in eEF1A2, whereas WD requires
Fig. 7 eEF1A2 expression is required for the normal initiation and progression of axotomy-induced WD. Confocal micrographs showing NMJs in 
immunohistochemically-labelled lumbrical muscle preparations from P25 wild-type (+/+) (A) and homozygous Wst (−/−) (B) mice at 24 h after a tibial 
nerve cut (green, 150 kDa neurofilaments; red, post-synaptic acetylcholine receptors). As expected, axotomy resulted in almost complete WD of motor 
nerve terminals and distal axon collaterals in lumbrical muscles of wild-type mice (A). Surprisingly, however, axotomy-induced WD was almost 
completely absent from homozygous Wst mice at the same time-point (B). (C) Montage of fluorescence micrographs showing YFP-labelled axons in a 
tibial nerve (supplying the lumbrical muscles) from a P25 Wst;YFP-H mouse at 24 h after a tibial nerve cut. Note the complete absence of any axonal 
pathology at this time-point. As expected, similar data were obtained from +/+ mice as gross morphological features of axonal WD do not begin to 
appear until 24 h after lesion (cf. Beirowski et al. 2005; data not shown). (D) Electron micrograph showing early ultrastructural signs of WD in +/+ tibial 
nerves at 24 h after axotomy (swollen and disrupted mitochondria; red arrows). (E) Electron micrograph showing lack of early ultrastructural signs of 
WD in −/− tibial nerves at 24 h after axotomy (mitochondria remained intact; red arrows). (F) Bar chart (mean ± SEM) showing the percentage of NMJs 
remaining in lumbrical muscles at 24 h post-axotomy (***P < 0.001; Kruskal Wallis test with Dunn’s post-hoc; n = 57 muscles, N = 19 mice +/+; n = 36 
muscles, N = 12 mice +/−; n = 36 muscles, N = 12 mice −/−). Note how < 5% of NMJs remained intact in muscles from wild-type mice, whereas ~80% 
of NMJs remained intact in muscles from homozygous Wst mice. (G) Bar chart (mean ± SEM) showing the percentage of NMJs remaining in lumbrical 
muscles from homozygous Wst mice at 24 and 48 h post-axotomy (n = 36 muscles, N = 12 mice −/− 24 h; n = 6 muscles, N = 2 mice −/− 48 h). Note 
how ~50% of NMJs remained intact in muscles from homozygous Wst mice even at 48 h post-axotomy. Scale bars: 50 μm (A and B), 200 μm (C), 
2 μm (D and E).
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eEF1A2 expression. This finding contradicts, to some extent,
an emerging view that many axonal and synaptic degen-
erative pathways converge onto common underlying
mechanisms (cf. Coleman, 2005). Fourth, they suggest that
eEF1A2-dependent molecular cascades, potentially acting
via ZPR1-dependent pathways, may be capable of modify-
ing the type and/or severity of neurodegenerative path-
ways instigated in lower motor neurons. The current study
therefore highlights the significant potential that exists
for further investigations into the molecular pathways acting
downstream of eEF1A2 to provide novel insights into neuro-
degenerative cascades resident in axonal and synaptic
compartments of lower motor neurons.
Can deficiencies in protein synthesis explain the 
neurodegenerative phenotype in Wst mice?
The most parsimonious explanation for the current find-
ings is that defects in protein synthesis, resulting directly
from a loss of eEF1A2 expression and function, are respon-
sible for triggering dying-back pathways and for the delay
in WD. There is little doubt that deficiencies in eEF1A pro-
teins lead to disruption of protein synthesis (Shultz et al.
1982; Chambers et al. 1998; Pan et al. 2004). Moreover, the
protein synthesis machinery is known to influence axonal
and synaptic form and function in neuronal cells (Piper &
Holt, 2004; Grossman et al. 2006; McCann et al. 2007), and
eEF1A is known to be important for local protein synthesis
determining synaptic stability and function (Giustetto
et al. 2003). However, although protein synthesis has been
shown to influence neurodegeneration of axons and
synapses in vitro (e.g. Stavisky et al. 2003), the influence
of protein synthesis on neurodegenerative mechanisms
resident in axons and synapses in vivo remains unclear.
It is not currently possible to directly visualize or measure
de-novo protein synthesis in distal axonal and/or neuro-
muscular synaptic compartments with any accuracy, ruling
out the possibility of definitively linking the induction
of dying-back pathways to deficiencies in protein synthesis.
Similarly, the current data do not allow us to directly link the
inhibition of WD with deficiencies in local protein synthe-
sis. However, Wst mice are likely to provide an ideal model
system within which to further investigate downstream
molecular mechanisms once more sensitive techniques
to measure local neuronal protein synthesis become
available. Its attraction as an experimental model is
highlighted by the fact that eEF1A2 deficiencies are
restricted to neuronal cells and muscle, and are only insti-
gated post-natally.
Could non-canonical roles of eEF1A2 be responsible for 
the neurodegenerative phenotype in Wst mice?
Alternative hypotheses explaining the potential mecha-
nisms underlying modifications in dying-back pathways
and WD in Wst mice can be proposed in the light of other
known non-canonical functions of eEF1A proteins. For
example, several studies have implicated eEF1A proteins in
assembly and stability of the cytoskeleton, including roles
in actin binding and microtubule severing (Yang et al.
1990, 1993; Shiina et al. 1994). It is possible therefore that
the dying-back pathways instigated in Wst mice occur as a
direct result of perturbations in the stability of the axonal
and synaptic cytoskeleton. Moreover, a loss of ability to
transport the products of cytoskeletal disruption down the
distal axon may explain the inhibition of WD pathways. If
the latter were found to be true, it would provide experi-
mental support for the hypothesis that WD is triggered by
a signal that passes from the site of injury down to the
nerve terminal (Miledi & Slater, 1970). Alternatively, it is
possible that perturbations in synaptic plasticity pathways,
known to be modulated by eEF1A levels (Giustetto et al.
2003), lead to destablilization of the NMJ and induction of
dying-back pathology. However, it should be noted that it
has yet to be demonstrated that the eEF1A2 variant has
the same non-canonical roles previously attributed to non-
variant-specific eEF1A protein. It therefore also remains
possible that eEF1A2 has as yet unidentified roles that are
responsible for the phenotypes described in the current study.
It should also be noted that it is by no means certain that
the same downstream effects resulting from loss of
eEF1A2 in Wst mice are responsible for the dual effects on
dying-back pathways and WD pathways. Further mecha-
nistic experiments, beyond the scope of the current study,
are required to distinguish the specific characteristics or
molecular targets of eEF1A2 required to prevent a dying-
back neuropathy and/or inhibit the initiation and progres-
sion of WD.
Implications for the stability and vulnerability of lower 
motor neurons in human motor neuron disease
Although eEF1A2 mutations are not currently thought to
be directly responsible for any human neurodegenerative
conditions, the gene and its protein product are known to
interact with other proteins that regulate dying-back
pathology in human neurodegenerative conditions such
as the childhood motor neuron disease SMA. eEF1A pro-
teins assemble into complexes with the survival motor
neuron protein (SMN1; mutations in which cause SMA)
and a zinc finger protein (ZPR1) (Gangwani et al. 1998;
Mishra et al. 2007). The finding that dying-back pathology
occurring in Wst mice closely resembles lower motor
neuron pathology occurring in mouse models of SMA and in
ZPR1-deficient mice (Monani et al. 2000, 2003; Doran et al.
2006; Murray et al. 2008) prompted us to examine
whether the pathways modified by loss of eEF1A2 con-
verged onto those involving SMN and ZPR1. We found that
dying-back pathology in Wst mice cannot be attributed to
corresponding reductions in Smn protein levels, suggesting
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that dying-back pathology in Wst and Smn–/–;SMN2 mice
is not triggered by the same molecular cues. However, our
observation that ZPR1 protein levels were modestly
reduced in Wst mice, to a level similar to that found in
Smn–/–;SMN2 mice, raises the possibility of shared down-
stream mechanistic pathways focused around ZPR1. As
decreasing ZPR1 levels have been shown to correlate with
disease severity in SMA patients (Helmken et al. 2003) and
ZPR1 is known to be required for the normal maintenance
and localization of Smn protein (Gangwani et al. 2001), it
is tempting to speculate that ZPR1 is capable of playing an
important role in regulating lower motor neuron vulner-
ability in SMA and in Wst mice. Further investigations into
the expression and function of ZPR1 in Wst and Smn–/–
;SMN2 mice may therefore provide novel insights into cel-
lular and molecular cascades regulating the vulnerability
of motor neurons in disease. Moreover, as the current data
suggest that eEF1A2 is required to prevent pre-synaptic
degeneration via a dying-back neuropathy, it may also be
worth investigating the possibility of increasing levels of
eEF1A2, on its own or in combination with ZPR1, as a
potential neuroprotective strategy in dying-back neuro-
pathies, such as SMA.
Conclusions
In this study we have shown that loss of expression of the
translation elongation factor eEF1A2 triggers a dying-
back neuropathy characterized by early loss of motor
nerve terminals at the NMJ. In sharp contrast, in the same
motor neurons the process of WD was significantly
delayed following an experimental nerve lesion. This sug-
gests that dying-back pathology and WD are regulated by
fundamentally different mechanisms in vivo.
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